Stock Information

• Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
  Wed, May 6, 2026 11:14 PM
• RBC Capital Maintains Outperform on Viridian Therapeutics, Raises Price Target to $34
  Wed, May 6, 2026 12:24 PM
• Viridian Therapeutics, Inc. (VRDN) Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease Transcript
  Tue, May 5, 2026 5:31 PM
• Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
  Tue, May 5, 2026 4:07 PM
• Which stocks are gapping on Tuesday?
  Tue, May 5, 2026 2:30 PM
• Transcript : Viridian Therapeutics, Inc. - Special Call
  Tue, May 5, 2026 1:50 PM
• 12 Health Care Stocks Moving In Tuesday's Intraday Session
  Tue, May 5, 2026 1:05 PM
• Wondering what's happening in today's pre-market session?
  Tue, May 5, 2026 12:30 PM
• Rockwell Automation Posts Upbeat Q2 Results, Joins EverQuote, DigitalOcean And Other Big Stocks Moving Higher On Tuesday
  Tue, May 5, 2026 11:58 AM
• Viridian Therapeutics : REVEAL-2 Phase 3 Topline Results (Presentation)
  Tue, May 5, 2026 10:57 AM

Financial data not available